|
Delayed
London S.E.
03:57:11 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 53.50 GBX | +3.38% |
|
+5.94% | +12.39% |
| 08-19 | Hansard Global Announces Appointment of Philip Story as Chief Distribution Officer | CI |
| 07-17 | WINNERS & LOSERS: Itaconix revenue rises; Alumasc suspends CEO | AN |
| Market Cap | 70.66M 96.02M 82.43M 77.17M 133M 9.17B 133M 914M 357M 4.62B 361M 353M 15.3B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 70.66M 96.02M 82.43M 77.17M 133M 9.17B 133M 914M 357M 4.62B 361M 353M 15.3B | EV / Sales 2026 * |
0.76x | EV / Sales 2027 * | 0.69x |
| Free-Float |
45.51% | Yield 2026 * |
8.6% | Yield 2027 * | 8.6% |
| 1 day | +3.38% | ||
| 1 week | +5.94% | ||
| Current month | +4.90% | ||
| 1 month | +1.90% | ||
| 3 months | -0.93% | ||
| 6 months | +3.88% | ||
| Current year | +12.39% |
| 1 week | 50.5 | 55 | |
| 1 month | 48.4 | 56 | |
| Current year | 46 | 57 | |
| 1 year | 43.2 | 57 | |
| 3 years | 37.2 | 57 | |
| 5 years | 32.4 | 61.1 | |
| 10 years | 23.4 | 142.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Morfett
CEO | Chief Executive Officer | - | 2024-08-01 |
Ollie Byrne
DFI | Director of Finance/CFO | - | 2024-09-30 |
John Whitehouse
COO | Chief Operating Officer | - | 2023-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Polonsky
BRD | Director/Board Member | - | 2018-09-25 |
Philip Kay
CHM | Chairman | 70 | 2022-04-30 |
Ollie Byrne
BRD | Director/Board Member | - | 2024-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/2/25 | Sell | Chief Financial Officer | 35,714 | 0.0260% | ||
| 5/23/23 | Free | Chief Executive Officer | 74,899 | 0.0544% | ||
| 5/20/22 | Sell | Head of Human Resources | 18,000 | 0.0131% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.38% | +5.94% | +5.73% | +29.23% | 96.02M | ||
| +0.34% | +4.85% | +22.99% | +155.38% | 147B | ||
| +7.20% | +9.27% | +61.87% | +154.62% | 62.55B | ||
| +0.64% | +0.88% | -6.17% | +27.21% | 54.83B | ||
| +0.31% | +5.44% | +63.36% | +118.65% | 41.62B | ||
| +0.57% | +2.37% | +32.14% | +124.76% | 23.4B | ||
| -1.03% | -1.41% | -3.37% | +35.91% | 18.63B | ||
| +2.26% | +2.42% | +100.11% | +173.65% | 17.22B | ||
| +0.23% | +2.55% | +22.89% | +108.50% | 14.57B | ||
| +0.13% | +3.10% | +25.12% | +57.71% | 13.51B | ||
| Average | +1.41% | +3.11% | +32.47% | +98.56% | 39.39B | |
| Weighted average by Cap. | +1.50% | +6.12% | +32.11% | +121.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 93.06M 126M 109M 102M 175M 12.08B 176M 1.2B 470M 6.09B 475M 465M 20.15B | 102M 139M 119M 112M 193M 13.29B 193M 1.32B 517M 6.7B 522M 511M 22.16B |
| Net income | - | - |
| Net Debt | - | - |
Employees
181
Sector
Life & Health Insurance
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | GBX 53.50 | +3.38% | 18,580 |
| 26-08-27 | GBX 51.75 | +1.47% | 1,344 |
| 26-08-26 | GBX 51.00 | -0.97% | 30,327 |
| 26-08-25 | GBX 51.50 | -4.63% | 32,138 |
| 26-08-24 | GBX 54.00 | +5.88% | 5,593 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5175GBP
Average target price
0.6500GBP
Spread / Average Target
+25.60%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HSD Stock
Select your edition
All financial news and data tailored to specific country editions
















